Compressibility of tableting materials and properties of tablets with glyceryl behenate

1. I. Singh, P. Kumar, N. Rani and V. Rana, Investigation of diff erent lipid based materials as matrices designed to control the release of a hydrophobic drug, Int. J. Pharm. Sci. Drug Res. 1 (2009) 158-163.Search in Google Scholar

2. GATTEFOSSE, Lipid excipients for oral dosage forms, Documents for Oral route. h_ p://www.ga_ efosse. com/en/document-center/; last access July 15, 2013.Search in Google Scholar

3. S. H. A. El-Halim, M. M. Amin, O. N. El-Gazayerly and N. A. A. El-Gavad, Comparative study on the diff erent techniques for the preparation of sustained-release hydrophobic matrices of a highly water-soluble drug, Drug Discov. Ther. 4 (2010) 484-492.Search in Google Scholar

4. L. M. E. McIndoe, Glyceryl Dibehenate, in Handbook of Pharmaceutical Excipients (Eds. R. C. Rowe, P. J. Sheskey and S. C. Owen), 5th ed., Pharmaceutical Press, Washington 2006, pp. 304-305.Search in Google Scholar

5. GATTEFOSSE, Developing sustained release tablets with CompritolR 888 ATO, Formulation Guidelines, Version 2, Lyon, 2010.Search in Google Scholar

6. G. Ragnarsson, Force-displacement and Network Measurements, in Pharmaceutical Powder Compac tion Technology (Eds. G. Alderborn and Ch. Nystrom, Marcel Dekker Inc., New York 1996, pp. 77-96.10.1201/b14207-5Search in Google Scholar

7. A. Stamm and C. Mathis, Verpressbarkeit von Festen Hilfsstoff en fur Direk_ able_ ierung, Acta Pharm. Technol. 22 (1976) 7-16.Search in Google Scholar

8. J. T. Fell and J. M. Newton, Determination of tablet strength by diametral-compression test, J. Pharm. Sci. 59 (1970) 688-691; DOI: 10.1002/jps.2600590523.10.1002/jps.2600590523Search in Google Scholar

9. European Pharmacopoeia, 7th ed., Vol. 1, Council of Europe, Strasbourg 2010, pp. 256-263.Search in Google Scholar

10. V. A. Belousov, Choice of optimal pressure values in tableting medicinal powders, Khim. Farm. Zh. 10 (1976) 105-111.Search in Google Scholar

11. B. A. C. Carlin, Direct Compression and the Role of Filler Binders, in Pharmaceutical Dosage Forms: Tablets, Eds. L. L. Augsburger and S. W. Hoag), 3th ed., Informa Healthcare USA, Inc., New York 2008, Vol. 2, pp. 173-216.Search in Google Scholar

12. N. O. Iloanusi and J. B. Schwartz, The eff ect of wax on compaction of microcrystalline cellulose beads made by extrusion and spheronization, Drug Dev. Ind. Pharm. 24 (1998) 37-44; DOI: 10.3109/03639049809082350.10.3109/03639049809082350Search in Google Scholar

13. M. Roberts, D. Vellucci, S. Mostafa, C. Miolane and D. Marchaud, Development and evaluation of sustained-release CompritolR 888 ATO matrix mini-tablets, Drug Dev. Ind. Pharm. 38 (2012) 1068-1076; DOI: 10.3109/03639045.2011.638302.10.3109/03639045.2011.638302Search in Google Scholar

14. P. Costa and J. M. Sousa Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1. 10.1016/S0928-0987(01)00095-1Search in Google Scholar